These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 8097936

  • 1. Production of bioactive rabbit antibodies against the mutated receptor peptide TSH-R-HIS17 and detection of hypertriiodothyroninemia in the rabbit.
    Hirooka Y, Mitsuma T, Nogimori T, Ishizuki Y, Sakai J, Naruse M, Fukayama M.
    Biochem Mol Biol Int; 1993 Mar; 29(3):493-7. PubMed ID: 8097936
    [Abstract] [Full Text] [Related]

  • 2. In vivo stimulation of thyroid hormone release by rabbit antibodies with thyroid stimulating activity raised against the mutated receptor peptide TSH-R-HIS17.
    Hirooka Y, Mitsuma T, Nogimori T, Ishizuki Y, Sakai J, Naruse M, Fukayama M.
    Life Sci; 1993 Mar; 53(8):659-64. PubMed ID: 8102469
    [Abstract] [Full Text] [Related]

  • 3. [Thyroid stimulating activity of human TSH-R peptide antibody].
    Endo T, Onaya T.
    Nihon Rinsho; 1994 Apr; 52(4):1043-7. PubMed ID: 7515120
    [Abstract] [Full Text] [Related]

  • 4. Discrete characteristics of antibodies raised against thyrotropin receptor-related peptides whose sequences are not conserved in the luteinizing hormone/chorionic gonadotropin receptor.
    Murakami M, Miyashita K, Mizuma H, Yamada M, Iriuchijima T, Takeuchi T, Mori M.
    J Clin Endocrinol Metab; 1996 May; 81(5):1747-52. PubMed ID: 8626828
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of epitopes for TSH receptor autoantibodies using TSH receptor/LH-CG receptor chimeras].
    Tahara K, Yamamoto K, Tamura Y, Yoshida S.
    Nihon Rinsho; 1994 Apr; 52(4):1031-6. PubMed ID: 7515118
    [Abstract] [Full Text] [Related]

  • 6. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
    Vitti P, Chiovato L, Fiore E, Mammoli C, Rocchi R, Pinchera A.
    Acta Med Austriaca; 1996 Apr; 23(1-2):52-6. PubMed ID: 8767515
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.
    Watanabe Y, Tahara K, Hirai A, Tada H, Kohn LD, Amino N.
    Thyroid; 1997 Feb; 7(1):13-9. PubMed ID: 9086564
    [Abstract] [Full Text] [Related]

  • 10. Loss of variability in Graves' disease: stimulatory TSH-receptor antibodies bind to the TSH-receptor in a continued, non-pulsatile and non-chaotic fashion.
    Schuppert F, Diegelmann B, Geest T, Wagner TO, von zur Mühlen A.
    Chronobiologia; 1994 Feb; 21(1-2):21-32. PubMed ID: 7924634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK, Plicht M, Lax H, Hirche H, Quadbeck B, Mann K, Steuhl KP, Esser J, Morgenthaler NG.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [Abstract] [Full Text] [Related]

  • 13. [Topics on immunogenic regions in TSH receptors for thyroid disease].
    Murakami M, Mori M.
    Rinsho Byori; 1993 Feb; 41(2):128-35. PubMed ID: 7689665
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [On the localization of the binding site(s) of antibodies against TSH receptor using synthetic peptides].
    Sakata S, Matsui K, Sarui H, Takuno H, Yasuda K.
    Nihon Rinsho; 1994 Apr; 52(4):1037-42. PubMed ID: 7515119
    [Abstract] [Full Text] [Related]

  • 16. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
    Schott M, Minich WB, Willenberg HS, Papewalis C, Seissler J, Feldkamp J, Bergmann A, Scherbaum WA, Morgenthaler NG.
    Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Binding, stimulating and blocking TSH receptor antibodies to the thyrotropin receptor as predictors of relapse of Graves' disease after withdrawal of antithyroid treatment.
    Quadbeck B, Hoermann R, Hahn S, Roggenbuck U, Mann K, Janssen OE.
    Horm Metab Res; 2005 Dec; 37(12):745-50. PubMed ID: 16372228
    [Abstract] [Full Text] [Related]

  • 20. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H, Kuwert T, Lohmann T.
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.